Fior Markets launched a study titled“Global Botulinum Market by Product Type (Type A, Type B), End Use(Therapeutic, Aesthetic), Regions”,and Global Forecast 2018-2025.

The global bolulinum market is expected to grow from USD 4.26 Billion in 2017 to USD 7.96 Billion by 2025, at a CAGR of 8.16% during the forecast period from 2018-2025.Increasing demand for minimally invasive and non-invasive surgical procedures coupled with continuous launch of novel products for enhancement of facialfeatures are anticipated to be the major driving forces for the market growth.


Type A product segment had a market value of USD 3.51 billion in 2017

Product type is segmented in to type A and type B. Type A botulinum products such as Botox and Dysport are easily available in the market. These products are widely used in the removal of glabellar lines as well as in treating medical conditions such as severe primary axillary hyperidrosis, blepharospasm and cervical dystonia. On account of these aforementioned factors type A product segment emerged as the leader in global otulinum market with USD 3.51 billion revenue in 2017. Owing to to its rising application in the treatment of cervical dystonia, the type B segment is projected to grow at an increased CAGR of 10.79% over the forecast period.

Therapeutic segment is anticipated to grow at a CAGR of 10.49% in 2018-2025

End Use segment is divided into aesthetics and therapeutic. Aesthetics segment led the global botulinum market with USD 2.67 billion revenue in 2017. Increased utilization of botulinum products in the treatment of medical conditions such as blepharospasm, cervical dystonia and hyperdrosis is anticipated to propel therapeutic segment to grow at the highest CAGR of 10.49% over the forecast period. Owing to its immense application value in treating frown lines, crow’s feet lines, and glabellar lines, the aesthetics segment emerged as the leading segment with USD 2.67 billion revenue in 2017.


Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa.High levels of per capita disposable income, availability of variety of aesthetic treatments and rising geriatric population were the factors that led North America region to emerge as the largest market for the botulinum with USD 1.97 billion 2017. Asia Pacific region is expected to grow at the highest CAGR of 11.04% over the forecast period.

Competitive Analysis: Major players in the global botulinummarket are Allergan, Inc., Ipsen Group, MerzPharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc. (US), Lanzhou Institute of Biological Products Co. Ltd., Revance Therapeutics, Inc., Huons Global, Evolus, Inc,Hugel  among others

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211